William Eric Barlow

机构：Fred Hutch Cancer Center, Cancer Research And Biostatistics · ORCID：0000-0003-4651-2282

发表论文 454 篇 · 总被引 32289 次 · h-index 92

代表论文

• TROPION-Breast03: a randomized phase III global trial of datopotamab deruxtecan ± durvalumab in patients with triple-negative breast cancer and residual invasive disease at surgical resection after neoadjuvant therapy (2024 · Therapeutic Advances in Medical Oncology · 被引 49)
• Long-Term Adverse Effects and Complications After Prostate Cancer Treatment (2024 · JAMA Oncology · 被引 38)
• Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221 (2023 · Journal of the National Comprehensive Cancer Network · 被引 30)
• Evaluating the Utility and Privacy of Synthetic Breast Cancer Clinical Trial Data Sets (2023 · JCO Clinical Cancer Informatics · 被引 22)
• Correlation of serum anti-Müllerian hormone (AMH) levels on identification of premenopausal patients (pts) with hormone receptor positive (HR+), HER2-negative, node-positive breast cancer most likely to benefit from adjuvant chemotherapy in SWOG S1007 (RxPONDER). (2024 · Journal of Clinical Oncology · 被引 21)
• Radiotherapy Use and Incidence of Locoregional Recurrence in Patients With Favorable-Risk, Node-Positive Breast Cancer Enrolled in the SWOG S1007 Trial (2023 · JAMA Oncology · 被引 21)